What is the optimal management of chronic rhinosinusitis in cystic fibrosis?

Current Opinion in Otolaryngology and Head & Neck Surgery, 01/09/2014

Over the past four decades, the average life expectancy for patients with cystic fibrosis (CF) has increased from 13 to 37 years of age. With increasing survival and improved pulmonary management, otolaryngologists are now seeing an increasing number of CF patients with chronic rhinosinusitis (CRS). Although CRS is a commonly treated disease process, there are a number of subtleties specific to CF. As the life expectancy of CF patients increases, quality of life issues gain importance. It is essential for otolaryngologists to understand the current therapeutic modalities to treat this challenging subset of CRS patients. With increasing life expectancy in CF, patients will require long–term follow–up with an otolaryngologist. Understanding the intricacies of the presentation of this disease in patients with CF is important for optimizing management.

Print Article Summary Cat 2 CME Report